The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 444.50
Bid: 439.00
Ask: 445.00
Change: 14.50 (3.37%)
Spread: 6.00 (1.367%)
Open: 433.50
High: 453.50
Low: 433.50
Prev. Close: 430.00
IPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

16 Mar 2023 13:57

RNS Number : 2573T
Impax Asset Management Group plc
16 March 2023
 

Impax Asset Management Group plc

("Impax" or the "Company")

Directorate Changes

Impax, the AIM listed specialist investor focused on a more sustainable economy, is pleased to announce the appointment of Karen Cockburn as Executive Director on the Impax Board, effective today, following the conclusion of the Company's Annual General Meeting.

Karen Cockburn was appointed as Impax's Chief Financial Officer with effect from January 2023. In this role, Karen leads the Company's Finance function, including Investor Relations, has oversight of Governance arrangements and the Legal function, and is a member of Impax's Executive Committee, contributing to commercial and strategic business matters.

Karen is a qualified Chartered Accountant with over 25 years' financial and operational experience in financial services. Before joining Impax, Karen was Transformation CFO at Virgin Money plc, focused on the integration of Virgin Money and Clydesdale Banking Group. Previously, she spent nine years at Aegon in various strategy, transformation and finance leadership roles, latterly as Chief Financial Officer of Cofunds. Having qualified with KPMG, she spent her early career with GE Capital and Lloyds Banking Group. Karen is also a founder and board member of a digital start-up, Legado Technologies Ltd. Karen is a fellow of the Irish Institute of Chartered Accountants and holds a BSc and MSc in Accounting and Finance from Queen's University, Belfast.

Karen becomes the second Executive Director on the Impax Board, along with Impax Chief Executive, Ian Simm.

The resignation of Non-Executive Director, Vince O'Brien, who previously notified the Board of his intention to retire after 13 years with Impax, became effective at today's AGM.

Sally Bridgeland, Chair, said: "I am delighted to welcome Karen as an Executive Director. She is a highly experienced professional, whose background in finance, technology and operations will be a tremendous asset to the Impax Board. I would also like to thank Vince personally for his commitment and considerable contribution to Impax over the years."

During the five years immediately preceding the date of this announcement, Karen Josephine Cockburn (née McCambridge), who is 54 years old, held the following directorships:

Current

Legado Technologies Limited

Impax Asset Management Limited

Impax Asset Management (AIFM) Limited

Impax Asset Management LLC

 

Previous

 

Lochside Nominees Limited

Andrews Nominees Limited

Witham Institutional Nominee Limited

Victoria Nominees Limited

Cofunds Nominees Limited

Cofunds Limited

Cofunds Leasing Limited

Dorset Nominees Limited

Minster Nominees Limited

Aegon Investment Solutions Limited

 

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

LEI number: 213800AJDNW4S2B7E680

- Ends -

 Enquiries:

 Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Head of Corporate Communications

p.french@impaxam.com

 

 

+44 (0)20 3912 3000

+44 (0)20 3912 3032

Montfort Communications

Gay Collins

Jack Roddan

impax@montfort.london

 

 

+44 (0)77 9862 6282

+44 (0)7825 670695

Peel Hunt LLP, Nominated Adviser and Joint Broker

Paul Shackleton or John Welch

 

+44 (0)20 7418 8900

 

Berenberg, Joint Broker

Gillian Martin

 

 

+44 (0)20 3207 7800

 

Notes to Editors - About Impax Asset Management

Founded in 1998, Impax is a specialist asset manager, with £40.4bn / US$48.6bn as of 28 February 2023 in both listed and private markets strategies, investing in the opportunities arising from the transition to a more sustainable global economy.

Impax believes that capital markets will be shaped profoundly by global sustainability challenges, including climate change, pollution and essential investments in human capital, infrastructure and resource efficiency. These trends will drive growth for well-positioned companies and create risks for those unable or unwilling to adapt.

The company seeks to invest in higher quality companies with strong business models that demonstrate sound management of risk. Impax offers a well-rounded suite of investment solutions spanning multiple asset classes seeking superior risk-adjusted returns over the medium to long term.

Impax has approximately 300 employees across its offices in the United Kingdom, the United States, Ireland and Hong Kong, making it one of the investment management sector's largest investment teams dedicated to sustainable development.

 

For more information: www.impaxam.com

Issued in the UK by Impax Asset Management Group plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange. Impax Asset Management Group plc is registered in England & Wales, number 03262305. AUM relates to Impax Asset Management Limited, Impax Asset Management (AIFM) Limited, Impax Asset Management Ireland Limited and Impax Asset Management LLC. Impax Asset Management Limited and Impax Asset Management (AIFM) Limited are authorised and regulated by the Financial Conduct Authority and are wholly owned subsidiaries of Impax Asset Management Group plc. Please note that the information provided and links from it should not be relied upon for investment purposes.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABXGDXLUBDGXL
Date   Source Headline
15th Apr 202410:42 amRNSForm 8.3 - Mondi Plc
10th Apr 20245:09 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSQ2 AUM Update
5th Apr 202412:47 pmRNSDirector/PDMR Shareholding
26th Mar 20242:32 pmRNSForm 8.3 - Mondi Plc
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 202412:22 pmRNSForm 8.3 - Mondi Plc
22nd Mar 202411:11 amRNSForm 8.3 - Mondi Plc
22nd Mar 20248:09 amRNSNotification of Major Holdings
15th Mar 202410:48 amRNSForm 8.3 - Mondi Plc
12th Mar 20245:34 pmRNSResult of AGM
12th Mar 20247:00 amRNSFebruary AUM update
11th Mar 202412:53 pmRNSForm 8.3 - Mondi Plc
6th Feb 20246:08 pmRNSDirector/PDMR Shareholding
17th Jan 20244:12 pmRNSDirector/PDMR Shareholding
12th Jan 20245:05 pmRNSHolding(s) in Company
12th Jan 202410:43 amRNSHolding(s) in Company
9th Jan 20247:35 amRNSAcquisition of fixed income assets
9th Jan 20247:00 amRNSQ1 AUM update
14th Dec 20234:20 pmRNSNotice of AGM
1st Dec 20234:20 pmRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSInvestor Presentation of Full Year Results
30th Nov 20233:50 pmRNSPublication of Annual Financial Report
29th Nov 202310:08 amRNSFinal Results
29th Nov 20237:01 amRNSDirectorate Change
29th Nov 20237:00 amRNSTrading Statement
23rd Nov 20233:07 pmRNSInvestor Presentation of Full Year Results
23rd Nov 20237:00 amRNSNotice of Results
30th Oct 20233:56 pmRNSHolding(s) in Company
9th Oct 20237:00 amRNSQ4 AUM update
3rd Oct 20233:14 pmRNSForm 8.3 - Renewi Plc
31st Aug 20236:25 pmRNSDirector/PDMR Shareholding
4th Aug 20235:38 pmRNSQuotedData's Weekly News & Interview
10th Jul 20237:00 amRNSQ3 AUM update
4th Jul 20234:02 pmRNSHolding(s) in Company
13th Jun 20231:30 pmRNSDirector/PDMR Shareholding
8th Jun 202312:40 pmRNSDirector/PDMR Shareholding
2nd Jun 20236:01 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.